1.
J Investig Allergol Clin Immunol
; 32(6): 486-488, 2022 12 15.
Article
En
| MEDLINE
| ID: mdl-35118941
2.
J. investig. allergol. clin. immunol
; 32(6): 486-488, 2022.
Article
En
| IBECS
| ID: ibc-213402
3.
J Investig Allergol Clin Immunol
; 31(2): 187-190, 2021 Apr 20.
Article
En
| MEDLINE
| ID: mdl-32614326
4.
J. investig. allergol. clin. immunol
; 31(2): 187-190, 2021. tab
Article
En
| IBECS
| ID: ibc-215199
5.
J Investig Allergol Clin Immunol
; 29(4): 300-302, 2019 Aug.
Article
En
| MEDLINE
| ID: mdl-31478526
Antineoplastic Agents/adverse effects , Drug Eruptions/diagnosis , Drug Eruptions/etiology , Exanthema/diagnosis , Exanthema/etiology , Phenylurea Compounds/adverse effects , Protein Kinase Inhibitors/adverse effects , Pyridines/adverse effects , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Desensitization, Immunologic , Drug Eruptions/therapy , Exanthema/therapy , Female , Humans , Liver Neoplasms/complications , Liver Neoplasms/drug therapy , Middle Aged , Phenylurea Compounds/administration & dosage , Protein Kinase Inhibitors/administration & dosage , Pyridines/administration & dosage , Severity of Illness Index , Treatment Outcome
6.
J. investig. allergol. clin. immunol
; 29(4): 300-302, 2019. tab
Article
En
| IBECS
| ID: ibc-188753
No disponible
Humans , Female , Middle Aged , Antineoplastic Agents/adverse effects , Drug Eruptions/diagnosis , Drug Eruptions/etiology , Exanthema/diagnosis , Exanthema/etiology , Phenylurea Compounds/adverse effects , Protein Kinase Inhibitors/adverse effects , Pyridines/adverse effects , Antineoplastic Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols , Desensitization, Immunologic , Drug Eruptions/therapy , Exanthema/therapy , Liver Neoplasms/drug therapy , Pyridines/administration & dosage , Severity of Illness Index , Treatment Outcome
7.
Hautarzt
; 51(3): 192-5, 2000 Mar.
Article
De
| MEDLINE
| ID: mdl-10789082
Pachyonychia congenita (PC) is a rare ectodermal dysplasia with variable expression. The condition is usually inherited as an autosomal dominant trait. Several classifications of PC have been proposed. Feinstein and colleagues suggested four clinical types of PC. Type II, the Jackson-Lawler-Syndrome, is characterized by multiple epidermal cysts, palmoplantar bullae and hyperhidrosis as well as natal teeth in addition to the main findings of pachyonychia, palmoplantar hyperkeratosis and follicular keratosis. We report two patients (father and son) with Jackson-Lawler-Syndrome and describe in detail pathogenesis, diagnostic criteria and treatment approaches as well as the different classifications of pachyonychia congenita.
Ectodermal Dysplasia/genetics , Nails, Malformed , Adolescent , Biopsy , Child, Preschool , Ectodermal Dysplasia/classification , Ectodermal Dysplasia/pathology , Humans , Male , Middle Aged , Skin/pathology , Syndrome